Searched for
MODAFINIL SALES US
Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...- Stocks in the news: Zee Entertainment, Divi's Labs, Sun Pharma, JSPL and Ashok LeylandHere’s a list of stocks which may hog limelight in today’s session.
- There’s hope yet for Sun investorsThe disappointment was accentuated as Q2 results came after encouraging results in the preceding two quarters.
- Sun Pharma profits drag on possible anti-trust settlementSun Pharma posted a total income of Rs 6846 crore, a 4 per cent growth.
- Sun Pharma climbs 2% on USFDA approvalThe drug in question is CEQUA (cyclosporine ophthalmic solution) 0.09 per cent.
- Sun Pharma's Q3 net profit plunges 75%, hit by US taxesThe company had reported consolidated profit of Rs 1,471.82 crore in the corresponding quarter of last year.
- Analysis: Sun Pharma has no quick cheer for investors; H2 is a ray of hopePerformance was affected by a sharp decline in sales of Taro, its US listed subsidiary , pricing pressure in the US market, and the impact ...
- Beyond Sun's pain is a promise of specialty segment: AnalystsSome analysts suggested that investors willing to overlook the subdued outlook.
- Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma lossSun was tipped into a loss this quarter after it agreed to pay plaintiffs including Canadian rival Apotex to settle a lawsuit over sleep-di...
- Sun Pharma disappoints in Q1; posts Rs 424.92 crore loss on one-time litigation costThe pharma major had reported a profit of Rs 2,033.71 crore in the same quarter last year.
- Top stocks in focus on Monday, 10 July 2017IDFC and Shriram Group agreed create the largest retail-focused bank in the country
Load More
